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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the effectiveness of continuous or intermittent CTG monitoring during labour with an ES compared with (1) continuous
or intermittent CTG monitoring during labour without an ES or (2) intermittent auscultation with a Pinard stethoscope or hand-held
Doppler ultrasound device.
B A C K G R O U N D
Intrapartum fetal hypoxia (shortage of oxygen) is a serious com-
plication of labour which increases the risk of perinatal mortal-
ity and morbidity, including hypoxic ischaemic encephalopathy
(acute or subacute brain injury due to asphyxia), cerebral palsy
and developmental delay (Dilenge 2001; Fatemi 2009; McIntyre
2013). Whereas a healthy, term baby has a baseline heart rate be-
tween 110 and 160 beats per minute, moderate variations in heart
rate amplitude and natural accelerations from its baseline heart
rate, this may not be the case for the hypoxic baby (ACOG 2009;
Liston 2007; NICE 2007; RANZCOG 2006). In contrast, a hy-
poxic baby may display minimal or a complete absence of heart
rate variation and accelerations as well as have marked deceler-
ations from its baseline heart rate values (ACOG 2009; Liston
2007;NICE 2007; RANZCOG2006). Since abnormal fetal heart
rate patterns may signify poor oxygenation and thus potential fe-
tal compromise, maternal care professionals often perform fetal
assessment during labour.
Cardiotocography (CTG, also known as electronic fetal heart rate
monitoring) and intermittent auscultation of the fetal heart rate
are the most common forms of fetal assessment during labour
(ACOG 2009; Liston 2007; NICE 2007; RANZCOG 2006). In
brief, CTG records the fetal heart rate and maternal uterine ac-
tivity via two transducers usually placed on the mother abdomen;
an ultrasound transducer measures fetal heart rate and a pressure
transducermeasures uterine contractions. Fetal heart rate and uter-
ine contractions are printed on a strip known as a CTG trace or
presented directly on a visual display unit to help identify abnor-
mal readings. In contrast, intermittent auscultation is a method
of listening to the baby’s heart rate using a Pinard (fetal stetho-
scope) or a hand-held Doppler ultrasound device. The rationale
underpinning both forms of fetal assessment is that babies who are
at risk of becoming compromised can be identified early so that
appropriate recourse can be made (i.e. more intensive monitoring
or expedited birth of the baby) (ACOG 2009; Liston 2007; NICE
2007; RANZCOG 2006).
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Description of the condition
In the early half of the twentieth century, intermittent ausculta-
tion served as the primary form of fetal assessment (Liston 2007).
Technological advancements during this time period led to the de-
velopment of CTG, and this method of fetal assessment was sub-
sequently introduced into maternity care in the late 1960s (Chez
2011). Despite early beliefs that CTG could potentially supersede
intermittent auscultation (Liston 2007), since its induction, there
has been a growing professional debate on the efficacy of CTG
monitoring (Alfirevic 2013; Chauhan 2008; Devane 2012; Hill
2012; Miller 2011a). Although CTG monitoring is typically re-
served for high-risk pregnancies, in the many parts of the devel-
oped world, more than three-quarters of babies will be assessed us-
ing CTG (ACOG 2009; Devane 2007; Devane 2012). Yet, CTG
has a relatively low specificity (a high false positive rate) for iden-
tifying fetal hypoxia and associated complications (Miller 2011a).
For example, the false positive rate for the most abnormal of fetal
heart rate patterns, the detection of cerebral palsy, has been re-
ported as high as 99.8% (Nelson 1996). This lack of specificity
can be attributed, in part, to the variability in interpretation of
fetal heart rate traces. Despite guidelines for CTG interpretation,
substantial inter- and intra-observer variation in interpretation
has been reported among maternity care providers (Blix 2003;
Chauhan 2008; Devane 2005; Figueras 2005). Misinterpretation
of fetal heart rate traces can lead to poor decisions, which can result
in unnecessary intervention or delay or withholding of necessary
intervention. Together, this can impact on the risks of operative
birth, perinatal asphyxia, hypoxic ischaemic encephalopathy and
perinatal death.
Given these clinical implications, substantial research has investi-
gatedCTGmonitoring in its current form versus alternativemeth-
ods. In a recent systematic review, women with signs of labour
who received a short, 20-minute CTG tracing on admission to
the maternity ward were more likely to have a caesarean birth
than women who were monitored using intermittent auscultation
(risk ratio (RR) 1.20; 95% confidence interval (CI) 1.00 to 1.44)
(Devane 2012). A related review found that in comparison to in-
termittent auscultation, continuous CTG during labour signifi-
cantly decreased the risk of neonatal seizures (RR 0.50; 95% CI
0.31 to 0.80), though it did not decrease the risk of cerebral palsy
(RR 1.75; 95% CI 0.84 to 3.63) (Alfirevic 2013). Further, con-
tinuous CTG was associated with significantly higher rates of cae-
sarean (RR 1.63; 95% CI 1.29 to 2.07) and instrumental births
(RR 1.15; 95% CI 1.01 to 1.33). Thus, while CTG can provide
critical information to maternity care providers, it is not without
limitations.
Description of the intervention
First developed in the 1960s, expert systems (ESs) represent a type
of applied artificial intelligence designed to assist in complex deci-
sion-making (Liao 2005). In a healthcare context, ESs synthesise
a computerised knowledge base derived from expert opinion with
individual patient data to guide users towards possible diagnosis or
treatment decisions (Liao 2005). To process data, an ES may ap-
ply rule-based algorithms or neural networks (i.e. a model of pat-
tern recognition based on previously collected data) (McCartney
2000; McCartney 2011); notably, however, there are numerous
other ES methodologies (Liao 2005). Requirements for ESs vary;
systems may be web-based or supported on a stand alone personal
computer. ESs are paperless and often represent real-time, which
is critical in healthcare environments where changes in health sta-
tus can occur rapidly. Advancements in ESs have led to their inte-
gration in a wide range of clinical settings, including cardiac care
(Chi 2012; Seto 2012), cancer diagnosis (Issac Niwas 2012; Yang
2012) and diabetes diagnosis (Basciftci 2011; Picon 2012).
The potential for ESs in maternity care is also well recognised,
and as a result, there has been an increasing interest in developing
ESs for CTGmonitoring (Ayres-de-Campos 2010; Greene 1996).
Such an ES would combine information on maternal and fetal
characteristics, which may include fetal heart rate, electrocardio-
gram (ECG) waveform, uterine contractions and/or gestational
age, to provide a comprehensive overview of the labour and/or
issue an alert if the baby’s status becomes critical. ES-issued alerts
may not only advise the user on potentially suitable intervention
but also provide underlying reasons for this recommendation, sim-
ulating reasoning capacity that can be interpreted easily by the
user (Liao 2005).
How the intervention might work
Despite controversy surrounding its ubiquitous use, CTG mon-
itoring continues to be recommended by a number of profes-
sional organisations for the monitoring of at least specific sub-
groups of pregnant women (Miller 2011a). Yet, there is general
consensus that measures must be taken to improve its interpreta-
tion (Chez 2011). For this reason, CTG clinical definitions and
guidelines have undergone extensive review (ACOG 2009; Liston
2007; NICE 2007; RANZCOG 2006) and training programmes
have been recommended and evaluated (Pehrson 2011). Arguably,
however, guidelines and educational interventions alone may be
insufficient in reducing inter-observer differences (Devoe 2000).
Although complementary measurements to enhance CTG inter-
pretation, such as fetal pulse oximetry, lactate level measurements
and fetal ECG waveform analysis, have been investigated, to date,
these techniques have conferred limited advantages over conven-
tional CTGmonitoring (East 2007; East 2010; Neilson 2012). In
particular, issues in interpretability were reported for ECG wave-
form analysis, which may have impacted, in part, its utility as
an additional indicator of fetal compromise (Steer 2008). Conse-
quently, conventional CTG monitoring has remained the norm
across many maternity units.
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In this context, an ES for fetal assessment represents a potential
alternative mechanism to counter issues with observer bias and
improve interpretation of fetal heart rate tracings. Developing an
ES to improve CTG monitoring has been a goal in maternity care
for decades. Whereas earlier versions displayed only limited suc-
cesses, substantial advances have been made in intelligence soft-
ware (Devoe 2000; Greene 1996; Guijarro-Berdiñas 2002; Steer
2008). Moreover, several observational studies have reported sig-
nificantly improved levels of agreement between practitioners in-
terpreting fetal heart rate patterns and identifying adverse out-
comes when assisted by an ES (Ayres-de-Campos 2010; Costa
2010; Costa 2010a). Thus, improving diagnostic interpretation
may result in improved identification of truly compromised babies
who warrant intervention.
Why it is important to do this review
Given that a high proportion of women will receive a CTG on
their admission to the labour ward and/or will be monitored con-
tinuously throughout their labour (ACOG 2009; Devane 2012),
it is critical to ensure that these CTGs are interpreted to the high-
est level of accuracy to minimise sub-optimal clinical decisions
and outcomes. Improved CTG interpretation has clear short- and
long-term health benefits for both mothers and babies through
possible prevention of serious neonatal complications and unnec-
essary operative birth. There are also important economic impli-
cations for the healthcare system. Due to long-term care require-
ments, neonatal cases of hypoxia and cerebral palsy can lead to
costly malpractice suits (Miller 2011b); thus, reducing morbid-
ity incidence through enhanced fetal assessment could potentially
have profound impact in this regard. Further, reducing unneces-
sary caesarean birth also benefits the healthcare system. Not only
is caesarean birth typically twice the cost of a vaginal birth (Fawsitt
2013; Henderson 2001), but also, particularly in a nulliparous
woman, may initiate a legacy of increased health costs (Grobman
2000) as a result of higher risk of subsequent caesarean birth and
medical complications (Garmi 2012; Lydon-Rochelle 2010).
O B J E C T I V E S
To evaluate the effectiveness of continuous or intermittent CTG
monitoring during labour with an ES compared with (1) contin-
uous or intermittent CTG monitoring during labour without an
ES or (2) intermittent auscultation with a Pinard stethoscope or
hand-held Doppler ultrasound device.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Wewill include all randomised, cluster-randomised and quasi-ran-
domised trials comparing continuous or intermittent CTG mon-
itoring during labour with an ES with continuous or intermit-
tent CTG monitoring without an ES. We will also include trials
that compare continuous or intermittent CTGmonitoring during
labour with an ES with intermittent auscultation with a Pinard or
hand-held Doppler.
Given the rapidity at which the health status of the mother and
baby can change during labour, cross-over trials are unsuitable for
the intervention under review and therefore will be excluded.
Types of participants
Pregnant women in labour and their babies.
Types of interventions
We will make the following comparisons.
1. Continuous CTG monitoring with an ES versus
continuous CTG monitoring alone.
2. Continuous CTG monitoring with an ES versus
intermittent CTG monitoring alone.
3. Continuous CTG monitoring with an ES versus
intermittent auscultation with a Pinard stethoscope or hand-held
Doppler ultrasound device.
4. Intermittent CTG monitoring with an ES versus
intermittent CTG monitoring alone.
5. Intermittent CTG monitoring with an ES versus
continuous CTG monitoring alone.
6. Intermittent CTG monitoring with an ES versus
intermittent auscultation with a Pinard stethoscope or hand-held
Doppler ultrasound device.
For the purposes of this review, we define continuous CTG mon-
itoring as monitoring of the fetal heart rate and uterine contrac-
tions, which commenced at some point during labour, and upon
commencement, was only discontinued for short periods of time.
We define intermittent monitoring asmonitoring of the fetal heart
rate anduterine contractionswhichwere not continuous but rather
at select intervals during labour.
We define an ES as any applied artificial intelligence tool designed
to assist in complex decision-making by integrating a comput-
erised knowledge base derived from expert opinion with individu-
alised patient data (Liao 2005). Given that the underlying factors
built into one ES may differ from others, where sufficient detail
is provided by trial authors, we will describe which maternal and
baby characteristics are included in the ES.
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Types of outcome measures
Primary outcomes
Maternal
1. Incidence of caesarean birth.
Baby
1. Incidence of perinatal mortality defined as fetal deaths (a
baby delivered without signs of life at > 22 weeks’ gestation and/
or with a birthweight > 500 g) and neonatal deaths (death of a
liveborn baby > 22 weeks’ gestation and/or with a birthweight >
500 g occurring within 28 days after birth) excluding lethal
congential anomalies.
2. Incidence of neonatal seizures.
3. Acidemia as evidenced by a pH less than 7.0 and/or a base
deficit greater than 12 mmol/L in umbilical arterial cord blood
or neonatal blood sample within the first hour of life, or both.
Secondary outcomes
Maternal
1. Incidence of operative vaginal birth (ventouse or forceps).
2. Incidence of fetal blood sampling.
3. Incidence of artificial rupture of amniotic membranes.
4. Incidence of oxytocin augmentation of labour.
Baby
1. Incidence of hypoxic ischaemic encephalopathy as defined
by trial authors.
2. Incidence of admission to neonatal special care and/or
neonatal intensive care unit.
3. Apgar score less than seven at five minutes.
Search methods for identification of studies
Electronic searches
We will contact the Trials Search Co-ordinator to search the
Cochrane Pregnancy and Childbirth Group’s Trials Register.
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. weekly searches of Embase;
4. handsearches of 30 journals and the proceedings of major
conferences;
5. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE and
EMBASE, the list of handsearched journals and conference pro-
ceedings, and the list of journals reviewed via the current aware-
ness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
For the purposes of this review, we will also include studies pub-
lished as abstracts if we are able to extract sufficient information on
the trial. In cases where insufficient data are published, we will first
contact the trial authors to access required information. If after
contacting the trial authors data remain insufficient, the abstract
will be excluded from our review.
In addition, we plan to search grey literature through Open Grey
and ProQuest Dissertation & Theses Database using the search
terms given in Appendix 1
Searching other resources
We will review citations of reference lists of included papers iden-
tified through the above search strategy and assess their suitability
for inclusion in the review.
We will not apply any language restrictions.
Data collection and analysis
The methods that will be carried out in this review were designed
in accordance with recommendations described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
Selection of studies
Two review authors (Jennifer E Lutomski (JEL) and Declan De-
vane (DD)) will independently assess for inclusion all the poten-
tial studies we identify as a result of the search strategy. We will
resolve any disagreement through discussion or, if required, we
will consult a third review author (CARyan (CAR), SarahMeaney
(SM) or Richard A Greene (RAG)).
Data extraction and management
We will design a form to extract data. For eligible studies, two
review authors (JEL and SM) will extract the data using the agreed
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form. We will resolve discrepancies through discussion or, if re-
quired, we will consult a third review author (DD). We will enter
data into ReviewManager software (RevMan 2011) and check for
accuracy. When information regarding any of the above is unclear,
we will attempt to contact authors of the original reports to pro-
vide further details.
Assessment of risk of bias in included studies
Two review authors (JEL and DD) will independently assess risk
of bias for each study using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
We will resolve any disagreement by discussion or by involving a
third review author.
(1) Random sequence generation (checking for possible
selection bias)
We will describe for each included study the method used to gen-
erate the allocation sequence in sufficient detail to allow an assess-
ment of whether it should produce comparable groups. We will
assess the risk of bias for sequence generation as:
• low risk (any truly random process, e.g. random number
table; computer random number generator);
• high risk (any non-random process, e.g. odd or even date of
birth; hospital or clinic record number); or
• unclear risk.
(2) Allocation concealment (checking for possible selection
bias)
We will describe for each included study the method used to con-
ceal allocation to interventions prior to assignment and will assess
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment. We
will assess the risk of bias for allocation concealment as:
• low risk (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk (e.g. open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth); or
• unclear risk.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
Given the additional equipment required to support an ES, it is
not possible for personnel to be blinded to the intervention in these
trials. However, we will describe the methods used, if any, to blind
women from knowledge of the intervention. We will consider that
studies are at low risk of bias if women were blinded or if we judge
that the lack of blinding would not likely impact results. We will
assess the risk of bias for blinding of participants as:
• low risk;
• high risk; or
• unclear risk.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We will describe for each included study the methods used, if any,
to blind outcome assessors from knowledge of which intervention
a woman received. We will assess blinding separately for different
outcomes or classes of outcomes. We will assess the risk of bias for
blinding of outcome assessment as:
• low risk;
• high risk; or
• unclear risk.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We will describe for each included study, and for each outcome
or class of outcomes, the completeness of data including attrition
and exclusions from the analysis. We will state whether attrition
and exclusions were reported and the numbers included in the
analysis at each stage (compared with the total randomised par-
ticipants), reasons for attrition or exclusion where reported, and
whether missing data were balanced across groups or were related
to outcomes. Where sufficient information is reported, or can be
supplied by the trial authors, we will re-include missing data in
the analyses which we undertake. We will assess the risk of bias for
incomplete outcome data as:
• low risk (e.g. no missing outcome data; missing outcome
data balanced across groups; < 20% missing data);
• high risk (e.g. frequency or reasons of missing data
imbalanced across groups; > 20% missing data); or
• unclear risk.
(5) Selective reporting (checking for reporting bias)
We will investigate the possibility of selective outcome reporting
bias by cross-checking outcomes of interest reported in the meth-
ods section to those reported in the results section of the trial pub-
lications. We will assess the risk of bias for selective reporting as:
• low risk (where it is clear that all of the study’s pre-specified
outcomes and all expected outcomes of interest to the review
have been reported);
• high risk (where not all the study’s pre-specified outcomes
have been reported; one or more reported primary outcomes
were not pre-specified; outcomes of interest are reported
incompletely and so cannot be used; study fails to include results
of a key outcome that would have been expected to have been
reported); or
• unclear risk.
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(6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
We will describe for each included study any important concerns
we have about other possible sources of bias. For instance, given
that certain biases are inherent to cluster-randomised trials due to
study design, in these types of trials we will investigate potential
biases due to recruitment, baseline imbalance, loss of clusters, in-
correct analysis and comparability with individually-randomised
trials. We will assess the risk of other forms of bias as:
• low risk;
• high risk; or
• unclear risk.
(7) Overall risk of bias
We will make explicit judgements about whether studies are at
high risk of bias, according to the criteria given in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
With reference to (1) to (6) above, we will assess the likely magni-
tude and direction of the bias and whether we consider it is likely
to impact on the findings. We will explore the impact of the level
of bias through undertaking sensitivity analyses (see Sensitivity
analysis) and will assess the overall risk of bias for each included
study as:
• low risk;
• high risk; or
• unclear risk.
Measures of treatment effect
Dichotomous data
For dichotomous data, we will present results as summary risk
ratios with 95% confidence intervals (95% CI).
Continuous data
For continuous data, we will use the mean difference with 95%
CI if outcomes are measured in the same way between trials. We
will use the standardised mean difference with 95% CI to com-
bine outcomes from trials that measure the same outcome but use
different scales (Higgins 2011).
Unit of analysis issues
Cluster-randomised trials
Wewill include cluster-randomised trials in the analyses alongwith
individually-randomised trials. We will adjust their sample sizes
using the methods described in the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011) using an estimate
of the intra-cluster correlation co-efficient (ICC) derived from the
trial (if possible), from a similar trial or from a study of a similar
population. If we use ICCs from other sources, we will report this
and conduct sensitivity analyses to investigate the effect of varia-
tion in the ICC. If we identify both cluster-randomised trials and
individually-randomised trials, we plan to synthesise the relevant
information. We will consider it reasonable to combine the re-
sults from both if there is little heterogeneity between the study
designs and the interaction between the effect of intervention and
the choice of randomisation unit is considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the effects of the
randomisation unit, i.e. to determine the sensitivity of the effect
estimates to inclusion and exclusion of cluster trials.
Multi-armed trials
Wewill include multi-armed trials in this review. To overcome po-
tential issues due tomultiple, correlated comparisons, wewill anal-
yse multi-armed trials using methods described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
If feasible in the context of the research question, we will first de-
termine if we can combine the multiple comparison groups to cre-
ate one relevant intervention group and one relevant comparison
group. If an appropriate pair-wise comparison cannot be created,
we will then derive an average (or weighted average) and variance
for all relevant intervention/comparison groups while accounting
for correlation between these comparisons.
Dealing with missing data
For included studies, wewill note levels of attrition.Wewill explore
the impact of including studies with high levels ofmissing data (we
judge this a priori to be greater than 20% for primary outcome)
in the overall assessment of treatment effect by using sensitivity
analysis.
For all outcomes, wewill carry out analyses, as far as possible, on an
intention-to-treat basis, i.e. we will attempt to include all women
randomised to each group in the analyses, and all women will
be analysed in the group to which they were allocated, regardless
of whether or not they received the allocated intervention. The
denominator for each outcome in each trial will be the number
of women randomised minus any women whose outcomes are
known to be missing.
Assessment of heterogeneity
Where studies are considered similar enough (based on consider-
ation of populations and interventions) to allow pooling of data
using meta-analysis, we will assess the degree of heterogeneity by
visual inspection of forest plots and by examining the Chi² test
for heterogeneity. We will assess statistical heterogeneity in each
meta-analysis using the T², I² and Chi² statistics. We will regard
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statistical heterogeneity as substantial if an I² is greater than 30%
and either the T² is greater than zero, or there is a low P value (less
than 0.10) in the Chi² test for heterogeneity.
Where we identify substantial clinical, methodological or statisti-
cal heterogeneity across included studies, wewill not report pooled
results from the meta-analysis but will instead use a narrative ap-
proach to data synthesis. In this event, we will attempt to explore
possible reasons for the heterogeneity by grouping studies that
have similar populations and interventions.
Assessment of reporting biases
If there are 10 or more studies in the meta-analysis, we will in-
vestigate reporting biases (such as publication bias) using funnel
plots. We will assess funnel plot asymmetry visually. If asymmetry
is suggested by a visual assessment, we will perform exploratory
analyses to investigate it.
Data synthesis
We will carry out statistical analysis using the Review Manager
software (RevMan 2011). We will use fixed-effect meta-analysis
for combining datawhere it is reasonable to assume that studies are
estimating the same underlying treatment effect: i.e. where trials
are examining the same intervention, and the trials’ populations
and methods are judged sufficiently similar. If there is clinical het-
erogeneity sufficient to expect that the underlying treatment ef-
fects differ between trials, or if substantial statistical heterogeneity
is detected, we will use random-effects meta-analysis to produce
an overall summary if an average treatment effect across trials is
considered clinically meaningful. The random-effects summary
will be treated as the average range of possible treatment effects
and we will discuss the clinical implications of treatment effects
differing between trials. If the average treatment effect is not clin-
ically meaningful, we will not combine trials.
If we use random-effects analyses, the results will be presented as
the average treatment effect with 95% CIs and the estimates of
T² and I².
Subgroup analysis and investigation of heterogeneity
If we identify substantial heterogeneity, we will investigate this
heterogeneity using subgroup analyses and sensitivity analyses.We
plan to carry out the following subgroup analysis.
1. Low-risk pregnancies versus high-risk pregnancies as
defined by the trial authors.
We will limit subgroup analyses to primary maternal and baby
outcomes (see Types of outcome measures).
We will assess subgroup differences by interaction tests available
within RevMan (RevMan 2011). We will report the results of
subgroup analyses quoting the Chi2 statistic and P value, and the
interaction test I² value.
Sensitivity analysis
We will perform sensitivity analyses based on trial quality by re-
peating our analysis among only those trials judged of ’high qual-
ity’. For the purposes of this review, ’high quality’ trials will be
defined as trials with low risk of bias due to allocation concealment
and low risk of bias due to incomplete outcome data.
We will limit sensitivity analyses to primary maternal and baby
outcomes (see Types of outcome measures). Sensitivity analyses
will also assist in investigating substantial statistical heterogeneity
if present (see Assessment of heterogeneity).
A C K N OW L E D G E M E N T S
We would like to acknowledge Lynn Hampson (Trials Search
Co-ordinator), Frances Kellie (Managing Editor) and Jim Neil-
son (Contact Editor) of the Cochrane and Pregnancy Childbirth
Group for their support throughout the drafting of this protocol.
JEL has been awarded a HRB Cochrane Review Training Fellow-
ship from the Health Research Board (HRB), Ireland.
As part of the pre-publication editorial process, this protocol has
been commented on by three peers (an editor and two referees
who are external to the editorial team) and the Group’s Statistical
Adviser.
The National Institute for Health Research (NIHR) is the largest
single funder of the Cochrane Pregnancy and Childbirth Group.
The views and opinions expressed therein are those of the authors
and do not necessarily reflect those of the NIHR, NHS or the
Department of Health.
7Expert systems for fetal assessment in labour (Protocol)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
R E F E R E N C E S
Additional references
ACOG 2009
ACOG Practice Bulletin No. 106. Intrapartum fetal heart
rate monitoring: Nomenclature, interpretation, and general
management principles. Obstetrics and Gynecology 2009;
114(1):192–202.
Alfirevic 2013
Alfirevic Z, Devane D, Gyte GML. Continuous
cardiotocography (CTG) as a form of electronic fetal
monitoring (EFM) for fetal assessment during labour.
Cochrane Database of Systematic Reviews 2013, Issue 5.
[DOI: 10.1002/14651858.CD006066.pub2]
Ayres-de-Campos 2010
Ayres-de-Campos D, Ugwumadu A, Banfield P, Lynch
P, Amin P, Horwell D, et al.A randomised clinical trial
of intrapartum fetal monitoring with computer analysis
and alerts versus previously available monitoring. BMC
Pregnancy Childbirth 2010;10:71. [DOI: 10.1186/
1471-2393-10-71]
Basciftci 2011
Basciftci F, Hatay OF. Reduced-rule based expert system by
the simplification of logic functions for the diagnosis of
diabetes. Computers in Biology and Medicine 2011;41(6):
350–6.
Blix 2003
Blix E, Sviggum O, Koss KS, Oian P. Inter-observer
variation in assessment of 845 labour admission tests:
comparison between midwives and obstetricians in the
clinical setting and two experts. BJOG: an international
journal of obstetrics and gynaecology 2003;110(1):1–5.
Chauhan 2008
Chauhan SP, Klauser CK, Woodring TC, Sanderson M,
Magann EF, Morrison JC. Intrapartum nonreassuring fetal
heart rate tracing and prediction of adverse outcomes:
interobserver variability. American Journal of Obstetrics and
Gynecology 2008;199(6):623 e1-5.
Chez 2011
Chez BF, Baird SM. Electronic fetal heart rate monitoring:
where are we now?. Journal of Perinatal and Neonatal
Nursing 2011;25(2):180-92; quiz 93-4.
Chi 2012
Chi CL, Nick Street W, Robinson JG, Crawford MA.
Individualized patient-centered lifestyle recommendations:
an expert system for communicating patient specific
cardiovascular risk information and prioritizing lifestyle
options. Journal of Biomedical Informatics 2012;45(6):
1164–74.
Costa 2010
Costa A, Santos C, Ayres-de-Campos D, Costa C,
Bernardes J. Access to computerised analysis of intrapartum
cardiotocographs improves clinicians’ prediction of newborn
umbilical artery blood pH. BJOG: an international journal
of obstetrics and gynaecology 2010;117:1288–93.
Costa 2010a
Costa MA, Ayres-de-Campos D, Machado AP, Santos C,
Bernardes J. Comparison of a computer system evaluation
of intrapartum cardiotocographic events and consensus of
clinicians. Journal of Perinatal Medicine 2010;38:191–5.
Devane 2005
Devane D, Lalor J. Midwives’ visual interpretation of
intrapartum cardiotocographs: intra- and inter-observer
agreement. Journal of Advanced Nursing 2005;52(2):
133–41.
Devane 2007
Devane D, Lalor J, Bonnar J. The use of intrapartum
electronic fetal heart rate monitoring: a national survey.
Irish Medical Journal 2007;100(2):360–2.
Devane 2012
Devane D, Lalor JG, Daly S, McGuire W, Smith V.
Cardiotocography versus intermittent auscultation of fetal
heart on admission to labour ward for assessment of fetal
wellbeing. Cochrane Database of Systematic Reviews 2012,
Issue 2. [DOI: 10.1002/14651858.CD005122.pub4]
Devoe 2000
Devoe L, Golde S, Kilman Y, Morton D, Shea K, Waller J.
A comparison of visual analyses of intrapartum fetal heart
rate tracings according to the new national institute of child
health and human development guidelines with computer
analyses by an automated fetal heart rate monitoring system.
American Journal of Obstetrics and Gynecology 2000;183(2):
361–6.
Dilenge 2001
Dilenge ME, Majnemer A, Shevell MI. Long-term
developmental outcome of asphyxiated term neonates.
Journal of Child Neurology 2001;16:781–92.
East 2007
East CE, Begg L, Colditz PB. Fetal pulse oximetry for
fetal assessment in labour. Cochrane Database of Systematic
Reviews 2007, Issue 2. Art. No.: CD004075. DOI:. [DOI:
10.1002/14651858.CD004075.pub3]
East 2010
East CE, Leader LR, Sheehan P, Henshall NE, Colditz PB.
Intrapartum fetal scalp lactate sampling for fetal assessment
in the presence of a non-reassuring fetal heart rate trace.
Cochrane Database of Systematic Reviews 2010, Issue 3.
[DOI: 10.1002/14651858.CD006174.pub2]
Fatemi 2009
Fatemi A, Wilson MA, Johnston MV. Hypoxic-ischemic
encephalopathy in the term infant. Clinics in Perinatology
2009;36(4):835–58.
Fawsitt 2013
Fawsitt CG, Bourke J, Greene RA, Everard CM, Murphy A,
Lutomski JE. At what price? A cost-effectiveness analysis
comparing trial of labour after previous caesarean versus
elective repeat caesarean delivery. PLoS One 2013;8(3):
e58577. DOI: 10.1371/journal.pone.0058577.
8Expert systems for fetal assessment in labour (Protocol)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figueras 2005
Figueras F, Albela S, Bonino S, Palacio M, Barrau E,
Hernandez S, et al.Visual analysis of antepartum fetal
heart rate tracings: inter- and intra-observer agreement
and impact of knowledge of neonatal outcome. Journal of
Perinatal Medicine 2005;33(3):241–5.
Garmi 2012
Garmi G, Salim R. Epidemiology, etiology, diagnosis, and
management of placenta accreta. Obstetrics and Gynecology
International 2012;2012:873929. [DOI: 10.1155/2012/
873929]
Greene 1996
Greene KR. Intelligent fetal heart rate computer systems in
intrapartum surveillance. Current Opinion in Obstetrics and
Gynecology 1996;8(2):123–7.
Grobman 2000
Grobman WA, Peaceman AM, Socol ML. Cost-effectiveness
of elective cesarean delivery after one prior low transverse
cesarean. Obstetrics and Gynecology 2000;95(5):745–51.
Guijarro-Berdiñas 2002
Guijarro-Berdiñas B, Alonso-Betanzos A, Fontenla-
Romero O. Intelligent analysis and pattern recognition in
cardiotocographic signals using a tightly coupled hybrid
system. Artificial Intelligence 2002;136:1–27.
Henderson 2001
Henderson J, McCandlish R, Kumiega L, Petrou S.
Systematic review of economic aspects of alternative modes
of delivery. BJOG: an international journal of obstetrics and
gynaecology 2001;108(2):149–57.
Higgins 2011
Higgins JPT, Green S, editors. Cochrane Handbook for
Systematic Reviews of Interventions Version 5.1.0 [updated
March 2011]. The Cochrane Collaboration, 2011.
Available from www.cochrane-handbook.org.
Hill 2012
Hill JB, Chauhan SP, Magann EF, Morrison JC, Abuhamad
AZ. Intrapartum fetal surveillance: review of three national
guidelines. American Journal of Perinatology 2012;29(7):
539–50.
Issac Niwas 2012
Issac Niwas S, Palanisamy P, Chibbar R, Zhang WJ. An
expert support system for breast cancer diagnosis using
color wavelet features. Journal of Medical Systems 2012;36
(5):3091–102.
Liao 2005
Liao SH. Expert system methodologies and applications -
a decade review from 1995 to 2004. Expert Systems with
Applications 2005;28(1):93–103.
Liston 2007
Liston R, Sawchuck D, Young D, Society of Obstetrics
and Gynaecologists of Canada, British Columbia Perinatal
Health Program. Fetal Health Surveillance: Antepartum
and intrapartum consensus guideline No. 197. Journal of
Obstetrics and Gynaecology Canada: JOGC 2007;29(9 Suppl
4):S3–S56.
Lydon-Rochelle 2010
Lydon-Rochelle MT, Cahill AG, Spong CY. Birth after
previous cesarean delivery: short-term maternal outcomes.
Seminars in Perinatology 2010 Aug;34(4):249–57.
McCartney 2000
McCartney PR. Computer analysis of the fetal heart rate.
Journal of Obstetric, Gynecologic, and Neonatal Nursing 2000;
29(5):527–36.
McCartney 2011
McCartney PR. Computer fetal heart rate pattern analysis.
MCN; American Journal of Maternal Child Nursing 2011;36
(6):397.
McIntyre 2013
McIntyre S, Taitz D, Keogh J, Goldsmith S, Badawi N,
Blair E. A systematic review of risk factors for cerebral
palsy in children born at term in developed countries.
Developmental Medicine and Child Neurology 2013;55(6):
499–508.
Miller 2011a
Miller DA. Intrapartum fetal heart rate definitions and
interpretation: evolving consensus. Clinical Obstetrics and
Gynecology 2011;54(1):16–21.
Miller 2011b
Miller L. Intrapartum fetal monitoring: liability and
documentation. Clinical Obstetrics and Gynecology 2011;54
(1):50–5.
Neilson 2012
Neilson JP. Fetal electrocardiogram (ECG) for fetal
monitoring during labour. Cochrane Database of
Systematic Reviews 2012, Issue 4. [DOI: 10.1002/
14651858.CD000116.pub3]
Nelson 1996
Nelson KB, Dambrosia JM, Ting TY, Grether JK. Uncertain
value of electronic fetal monitoring in predicting cerebral
palsy. New England Journal of Medicine 1996;334(10):
613–8.
NICE 2007
National Institute for Health and Clinical Excellence.
CG55 Intrapartum care: Care of healthy women and their
babies during childbirth. NICE Clinical Guidelines. UK
2007.
Pehrson 2011
Pehrson C, Sorensen JL, Amer-Wahlin I. Evaluation
and impact of cardiotocography training programmes:
a systematic review. BJOG: an international journal of
obstetrics and gynaecology 2011;118(8):926–36.
Picon 2012
Picon AP, Ortega NR, Watari R, Sartor C, Sacco IC.
Classification of the severity of diabetic neuropathy: a new
approach taking uncertainties into account using fuzzy
logic. Clinics (Sao Paulo) 2012;67(2):151–6.
RANZCOG 2006
Royal Australian and New Zealand College of Obstetricians
and Gynaecologists. Clinical Guidelines: Intrapartum
9Expert systems for fetal assessment in labour (Protocol)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fetal Surveillance. 2nd ed. East Melbourne, Australia:
RANZCOG. 2nd Ed. 2006.
RevMan 2011
The Nordic Cochrane Centre, The Cochrane Collaboration.
Review Manager (RevMan). 5.1. Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2011.
Seto 2012
Seto E, Leonard KJ, Cafazzo JA, Barnsley J, Masino C, Ross
HJ. Developing healthcare rule-based expert systems: case
study of a heart failure telemonitoring system. International
Journal of Medical Informatics 2012;81(8):556–65.
Steer 2008
Steer PJ. Has electronic fetal heart rate monitoring made a
difference?. Seminars in Fetal and Neonatal Medicine 2008;
13(1):2–7.
Yang 2012
Yang F, Tian J, Xiang Y, Zhang Z, Harrington Pde B. Near
infrared spectroscopy combined with least squares support
vector machines and fuzzy rule-building expert system
applied to diagnosis of endometrial carcinoma. Cancer
Epidemiology 2012;36(3):317–23.
∗ Indicates the major publication for the study
A P P E N D I C E S
Appendix 1. Search terms for Open Grey and ProQuest
Open Grey
medical equipment AND (fetal OR foetal OR birth OR labour OR labor OR childbirth)
expert systems AND (fetal OR foetal OR birth OR childbirth OR labor OR labour)
cardiotocograph OR cardiotocography
fetal monitoring OR foetal monitoring
(We will search for each line separately and assess results of each).
ProQuest Dissertations and Theses
all(fetal OR foetal OR birth OR childbirth OR obstetrics) AND all((electronic NEAR/1 monitoring OR expert NEAR/2 systems OR
intelligent NEAR/2 analysis OR computer NEAR/2 analysis OR cardiotocography OR cardiotocograph))
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